Hepatitis

Excessive energy drink consumption leads to acute hepatitis case

Excessive energy drink consumption leads to acute hepatitis case

By

A 50-year-old man presents to the emergency department with abdominal pain, nausea, jaundice, and dark urine.

Missed blood test results

Missed blood test results

By

A patient's positive hepatitis B results were overlooked for 7 years.

Healthcare issues of the LGBT community: What the primary care clinician should know

Healthcare issues of the LGBT community: What the primary care clinician should know

A greater understanding of the healthcare issues specific to the lesbian, gay, bisexual, and transgender community may improve the quality of care.

Poll indicates many people are unaware of hepatitis B vaccine

Poll indicates many people are unaware of hepatitis B vaccine

More than half of Americans polled were unsure or unaware of the existence of a hepatitis B vaccine.

Intradermal HBV vaccine safe, effective for intramuscular nonresponders

Intradermal HBV vaccine safe, effective for intramuscular nonresponders

No reports of adverse events with intradermal recombinant HBsAg-based vaccine.

Telbivudine prevents mother-to-infant HBV transmission

Telbivudine prevents mother-to-infant HBV transmission

Nearly all pregnant women with hepatitis B virus (HBV) taking telbivudine had undetectable levels of HBV DNA in cord blood.

Hepatitis B treatment 100% effective in preclinical trials

Hepatitis B treatment 100% effective in preclinical trials

The combination of entecavir and birinapant eradicated the hepatitis B virus in preclinical trials.

Increased HBV interventions necessary to reduce transmission

Increased HBV interventions necessary to reduce transmission

Strengthening current hepatitis B virus prevention and treatment efforts can reduce related mortality.

Hepatitis C treatment benefits lupus patients

Hepatitis C treatment benefits lupus patients

Immunosuppressive agents do not increase the risk of HCV flares in anti-HCV-positive lupus patients.

Antiviral treatment improves hepatitis B virus-related hepatocellular carcinoma survival rates

Antiviral treatment improves hepatitis B virus-related hepatocellular carcinoma survival rates

Overall survival was significantly improved for patients treated with nucleoside analogues (NAs) versus those who received no NAs.

Once-daily daclatasvir plus sofosbuvir yields high SVR in HCV

Once-daily daclatasvir plus sofosbuvir yields high SVR in HCV

By

Daclatasvir plus sofosbuvir demonstrated a sustained virological response in 98% of patients with genotype 1 hepatitis C infection.

NIH issues small business grant to encourage hepatitis research

NIH issues small business grant to encourage hepatitis research

Projects funded by the grant will aid public health efforts to reduce the burden of viral hepatitis in the United States.

Community organizations strengthen hepatitis prevention initiatives

Community organizations strengthen hepatitis prevention initiatives

A community-based organization focused on eliminating hepatitis-related health disparities issued a report detailing improvements that can be made for better hepatitis care.

Does extensive hepatitis C screening help or harm?

Does extensive hepatitis C screening help or harm?

By

The risk-benefit profile of more widespread hepatitis C screening is not sufficiently understood, researchers suggest.

Hepatitis C does not cause mental impairment in HIV patients

Hepatitis C does not cause mental impairment in HIV patients

Researchers have eliminated hepatitis C as the cause of impaired mental function in HIV patients.

Screen for hepatitis B in patients undergoing chemotherapy, transplantation

Screen for hepatitis B in patients undergoing chemotherapy, transplantation

To prevent reactivation, appropriate antiviral therapy should be given to patients who are found to be HBsAg positive.

FDA approves combination simeprevir and sofosbuvir for HCV treatment

FDA approves combination simeprevir and sofosbuvir for HCV treatment

Combination simeprevir and sofosbuvir has been approved by the FDA for treatment of chronic genotype 1 hepatitis C.

Focus shifts from HCV to fatty liver disease

Focus shifts from HCV to fatty liver disease

Fatty liver disease and other topics gained traction at the AASLD Annual Meeting as HCV therapy research plateaus.

USPSTF: Screen high-risk groups for HBV

USPSTF: Screen high-risk groups for HBV

Patients at risk for HBV infection include HIV-positive individuals, injection-drug users, and household contacts of those with HBV.

Lifelong latent HBV monitoring cost effective in China

Lifelong latent HBV monitoring cost effective in China

By

Identifying more patients with chronic hepatitis B virus, and increasing treatment, monitoring and drug adherence could translate to health gains.

Hepatitis C and eczema


Hepatitis C and eczema


Several dermatologic manifestations of hepatitis C infection have been described.

CDC updates HBV vaccination guidelines for HCWs

CDC updates HBV vaccination guidelines for HCWs

All should be vaccinated and undergo serologic testing

Boxed warning for HBV risk added to Rituxan, Arzerra

Boxed warning for HBV risk added to Rituxan, Arzerra

By

The FDA is updating the labels for two drugs to warn about the risk for immunosupression-related hepatitis B virus reactivation.

Standard of care for patients with elevated liver enzymes

Standard of care for patients with elevated liver enzymes

What is the standard of care for a patient with elevated liver function tests?

CDC: 61 ill in multistate hepatitis A outbreak

CDC: 61 ill in multistate hepatitis A outbreak

Illness possibly related to "Townsend Farms Organic Anti-Oxidant Blend" frozen berry, pomegranate mix.

Providers with HBV can keep practicing

Providers with HBV can keep practicing

By

Hepatitis B virus infection does not disqualify health-care workers from working.

What to do with a positive hepatitis C test

What to do with a positive hepatitis C test

If the treatment goal of viral eradicatication cannot be met, strive to slow disease progression, lower risk of liver cancer, and improve quality of life.

ART recommended for all with HIV, regardless of CD4 count

ART recommended for all with HIV, regardless of CD4 count

New recommendations state that all patients with HIV be treated with antiretroviral therapy (ART) regardless of CD4 cell count.

Hep B vaccine urged for adults with diabetes

Hep B vaccine urged for adults with diabetes

By

The CDC's Advisory Committee on Immunization Practices recommends hepatitis B virus vaccine for all unvaccinated patients aged 19 through 59 years with diabetes.

Hepatitis C therapy interferes with HIV treatment

Taking boceprevir with ritonavir-boosted HIV protease inhibitors together reduces the effectiveness of both therapies, the FDA announced.

Sign Up for Free e-newsletters